New Carriers for Bioadhesive Gastroretentive Drug Delivery Systems Based on Eudragit<sup>®</sup> EPO/Eudragit<sup>®</sup> L100 Interpolyelectrolyte Complexes

The aim of this study was the analysis of interpolyelectrolyte complexes (IPECs) based on Eudragit<sup>®</sup> EPO and Eudragit<sup>®</sup> L100 as prospective carriers for gastroretentive drug delivery systems (GRDDS) using two model drugs: metronidazole (MZ) and acyclovir (...

Full description

Bibliographic Details
Main Authors: Daria S. Gordeeva, Aleksandra V. Sitenkova (Bukhovets), Rouslan I. Moustafine
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Scientia Pharmaceutica
Subjects:
Online Access:https://www.mdpi.com/2218-0532/92/1/14
_version_ 1797239363157884928
author Daria S. Gordeeva
Aleksandra V. Sitenkova (Bukhovets)
Rouslan I. Moustafine
author_facet Daria S. Gordeeva
Aleksandra V. Sitenkova (Bukhovets)
Rouslan I. Moustafine
author_sort Daria S. Gordeeva
collection DOAJ
description The aim of this study was the analysis of interpolyelectrolyte complexes (IPECs) based on Eudragit<sup>®</sup> EPO and Eudragit<sup>®</sup> L100 as prospective carriers for gastroretentive drug delivery systems (GRDDS) using two model drugs: metronidazole (MZ) and acyclovir (ACR). Eudragit<sup>®</sup> EPO/L100 IPECs with different pH concentrations were characterized by different degrees of swelling in mimicking fasted stomach medium (0.1 M HCl) and saved their shape for 6 h. The microenvironmental changes in IPEC structures in acidic medium were investigated using FT-IR spectroscopy, thermal and elemental analysis. IPEC samples showed bioadhesive properties that were not significantly different from the positive control (Carbopol) in the test with the mucin compacts. The release rate of metronidazole (class I BCS) from IPEC matrices increased with the increasing degree of swelling. IPEC 1 provided 49.62 ± 6.20% and IPEC 2 reached 87.69 ± 5.15% of metronidazole release after 6 h in mimicking fasted stomach medium (0.1 M HCl). The total amount of released acyclovir (class III BCS) from IPEC 1 was 25.76 ± 5.67% and from IPEC 2 was 21.48 ± 5.00%. Release of both drugs was controlled by relaxation of polymeric chains in matrices according to the Peppas–Sahlin model. According to the received results, investigated interpolymer complexes are prospects for further evaluation as carriers for gastroretentive bioadhesive systems.
first_indexed 2024-04-24T17:50:21Z
format Article
id doaj.art-3f7bbd86e72c4bf0a0c7389d60d6a32e
institution Directory Open Access Journal
issn 0036-8709
2218-0532
language English
last_indexed 2024-04-24T17:50:21Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Scientia Pharmaceutica
spelling doaj.art-3f7bbd86e72c4bf0a0c7389d60d6a32e2024-03-27T14:03:27ZengMDPI AGScientia Pharmaceutica0036-87092218-05322024-02-019211410.3390/scipharm92010014New Carriers for Bioadhesive Gastroretentive Drug Delivery Systems Based on Eudragit<sup>®</sup> EPO/Eudragit<sup>®</sup> L100 Interpolyelectrolyte ComplexesDaria S. Gordeeva0Aleksandra V. Sitenkova (Bukhovets)1Rouslan I. Moustafine2Institute of Pharmacy, Kazan State Medical University, 16 Fatykh Amirkhan Street, Kazan 420126, RussiaInstitute of Pharmacy, Kazan State Medical University, 16 Fatykh Amirkhan Street, Kazan 420126, RussiaInstitute of Pharmacy, Kazan State Medical University, 16 Fatykh Amirkhan Street, Kazan 420126, RussiaThe aim of this study was the analysis of interpolyelectrolyte complexes (IPECs) based on Eudragit<sup>®</sup> EPO and Eudragit<sup>®</sup> L100 as prospective carriers for gastroretentive drug delivery systems (GRDDS) using two model drugs: metronidazole (MZ) and acyclovir (ACR). Eudragit<sup>®</sup> EPO/L100 IPECs with different pH concentrations were characterized by different degrees of swelling in mimicking fasted stomach medium (0.1 M HCl) and saved their shape for 6 h. The microenvironmental changes in IPEC structures in acidic medium were investigated using FT-IR spectroscopy, thermal and elemental analysis. IPEC samples showed bioadhesive properties that were not significantly different from the positive control (Carbopol) in the test with the mucin compacts. The release rate of metronidazole (class I BCS) from IPEC matrices increased with the increasing degree of swelling. IPEC 1 provided 49.62 ± 6.20% and IPEC 2 reached 87.69 ± 5.15% of metronidazole release after 6 h in mimicking fasted stomach medium (0.1 M HCl). The total amount of released acyclovir (class III BCS) from IPEC 1 was 25.76 ± 5.67% and from IPEC 2 was 21.48 ± 5.00%. Release of both drugs was controlled by relaxation of polymeric chains in matrices according to the Peppas–Sahlin model. According to the received results, investigated interpolymer complexes are prospects for further evaluation as carriers for gastroretentive bioadhesive systems.https://www.mdpi.com/2218-0532/92/1/14interpolyelectrolyte complexesEudragit<sup>®</sup>gastroretentive systemsdrug delivery systemsbioadhesive systemsmetronidazole
spellingShingle Daria S. Gordeeva
Aleksandra V. Sitenkova (Bukhovets)
Rouslan I. Moustafine
New Carriers for Bioadhesive Gastroretentive Drug Delivery Systems Based on Eudragit<sup>®</sup> EPO/Eudragit<sup>®</sup> L100 Interpolyelectrolyte Complexes
Scientia Pharmaceutica
interpolyelectrolyte complexes
Eudragit<sup>®</sup>
gastroretentive systems
drug delivery systems
bioadhesive systems
metronidazole
title New Carriers for Bioadhesive Gastroretentive Drug Delivery Systems Based on Eudragit<sup>®</sup> EPO/Eudragit<sup>®</sup> L100 Interpolyelectrolyte Complexes
title_full New Carriers for Bioadhesive Gastroretentive Drug Delivery Systems Based on Eudragit<sup>®</sup> EPO/Eudragit<sup>®</sup> L100 Interpolyelectrolyte Complexes
title_fullStr New Carriers for Bioadhesive Gastroretentive Drug Delivery Systems Based on Eudragit<sup>®</sup> EPO/Eudragit<sup>®</sup> L100 Interpolyelectrolyte Complexes
title_full_unstemmed New Carriers for Bioadhesive Gastroretentive Drug Delivery Systems Based on Eudragit<sup>®</sup> EPO/Eudragit<sup>®</sup> L100 Interpolyelectrolyte Complexes
title_short New Carriers for Bioadhesive Gastroretentive Drug Delivery Systems Based on Eudragit<sup>®</sup> EPO/Eudragit<sup>®</sup> L100 Interpolyelectrolyte Complexes
title_sort new carriers for bioadhesive gastroretentive drug delivery systems based on eudragit sup r sup epo eudragit sup r sup l100 interpolyelectrolyte complexes
topic interpolyelectrolyte complexes
Eudragit<sup>®</sup>
gastroretentive systems
drug delivery systems
bioadhesive systems
metronidazole
url https://www.mdpi.com/2218-0532/92/1/14
work_keys_str_mv AT dariasgordeeva newcarriersforbioadhesivegastroretentivedrugdeliverysystemsbasedoneudragitsupsupepoeudragitsupsupl100interpolyelectrolytecomplexes
AT aleksandravsitenkovabukhovets newcarriersforbioadhesivegastroretentivedrugdeliverysystemsbasedoneudragitsupsupepoeudragitsupsupl100interpolyelectrolytecomplexes
AT rouslanimoustafine newcarriersforbioadhesivegastroretentivedrugdeliverysystemsbasedoneudragitsupsupepoeudragitsupsupl100interpolyelectrolytecomplexes